Items where Author is "Schulz-Eying, Catrine"

Conference or Workshop Item

Mackensen, Andreas and Haanen, John B. A. G. and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva Maria and Heudobler, Daniel and Borchmann, Peter and Bokemeyer, Carsten and Klobuch, Sebastian and Kutsch, Nadine and Mueller, Fabian and Desuki, Alexander and Lueke, Florian and Wiegert, Erol and Flemmig, Carina and Schulz-Eying, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2023) CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 02-06, 2023, Chicago, IL.

Other

Mackensen, Andreas and Haanen, John B. A. G. and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva and Borchmann, Peter and Heudobler, Daniel and Ferstl, Barbara and Klobuch, Sebastian and Bokemeyer, Carsten and Desuki, Alexander and Lueke, Florian and Kutsch, Nadine and Mueller, Fabian and Smit, Eveline and Hillemanns, Peter and Karagiannis, Panagiotis and Wiegert, Erol and He, Ying and Ho, Thang and Kang-Fortner, Qing and Schlitter, Anna Melissa and Schulz-Eying, Catrine and Finlayson, Andrew and Flemmig, Carina and Kuehlcke, Klaus and Preussner, Liane and Rengstl, Benjamin and Tuereci, Oezlem and Sahin, Ugur (2023) CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. NATURE PORTFOLIO, BERLIN.